Portable and Wearable Dialysis Devices Market Revenue to Cross US$ 4,393.8 million in 2027 Lead By Quanta Dialysis Technologies, AWAK Technologies, Nipro

The portable and wearable dialysis devices market growth is attributed to factors such as increasing number of ESRD patients, and limited availability of organ donors. However, reimbursement concerns in emerging market and technical challenges in WAK and WDD development hinder the growth of the market.

B. Braun Melsungen AG; Baxter International Inc; AllMed Healthcare Management, Inc; Asahi Kasei Corporation; Fresenius Kabi AG; AWAK Technologies; Quanta Dialysis Technologies Ltd; Medtronic; and Nipro are among the leading companies operating in the portable and wearable dialysis devices market.

Get sample PDF Copy of portable and wearable dialysis devices market study @ https://www.theinsightpartners.com/sample/TIPRE00010481/?utm_source=OpenPR&utm_medium=10144

The portable and wearable dialysis devices market is expected to reach US$ 4,393.8 million in 2027 from US$ 3,023.1 million in 2019. The market is estimated to grow with a CAGR of 5.0% from 2020 to 2027.

Based on product type, the global portable and wearable dialysis devices market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment held a larger share of the market in 2019 on the back of the advantages of these devices and greater applicability of this technique in home-based services. Moreover, various companies operating in the market are engaged in the development of wearable and portable hemodialysis devices. For instance, in February 2020, Fist Assist Devices, LLC, a Silicon Valley startup, received European CE Mark approval for its eponymous wearable device named Fist Assist. The device works to widen up the vein's diameter while preparing for fistula placement.

Moreover, nearly 750,000 patients per year in the US are affected by ESRD. Internationally, the numbers are staggering. According to the estimates, 4 million people worldwide suffer from ESRD, and the number of patients diagnosed with the disease continues to increase at a rate of 5-7% per year. Taiwan, Japan, Mexico, the US, and Belgium currently have the highest prevalence of ESRD as per the data provided by the United States Renal Data System in 2019.

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00010481/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.